Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-010952
Filing Date
2022-02-17
Accepted
2022-02-17 18:10:06
Documents
1
Period of Report
2022-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6722
  Complete submission text file 0001209191-22-010952.txt   8151
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3135 HUTTON DRIVE BEVERLY HILLS CA 90210
Business Address
Jakobovits Aya (Reporting) CIK: 0001823901 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 22649892